Drug hypersensitivity in children: a retrospective analysis of 101 pharmacovigilance reports
- PMID: 33155108
- DOI: 10.1007/s00431-020-03859-2
Drug hypersensitivity in children: a retrospective analysis of 101 pharmacovigilance reports
Abstract
Our objective was to describe and discuss management of recent cases of drug hypersensitivity in children reported in a pharmacovigilance center. Two pediatric allergy units conducted a collaborative retrospective analysis of 101 adverse drug reactions reported to a regional pharmacovigilance center between January 2016 and July 2019. Time lapse between hypersensitivity reaction onset and allergy consultation varied from 1 month to 12 years. Sixty-two patients (61.4%) presented with immediate reactions, 11 (10.9%) with non-immediate reactions, and 28 (27.7%) had reactions impossible to classify through medical interview. Overall, 92 children (91%) were explored for simultaneously administered drugs. All 113 prick tests were negative, and 2 were uncertain. Among 108 intradermal tests, 2 were positive to penicillin and to an iodinated contrast medium, 105 were negative, and 1 was uncertain. Overall, 129 drug provocation tests were proposed. Nine provocation tests among 80 were positive (11.25%): 6 to penicillin, 1 to sulfonamide antibiotics, and 2 to non-steroidal anti-inflammatory drugs; the remaining 71 were negative. No severe reaction was observed during these tests. Finally, drug allergy was only retained in 11 reported cases (10.9%).Conclusion: These pharmacovigilance reports show the difficulty in defining drug allergy in children only by anamnesis, and that explorations, particularly provocation tests, should take place at a reasonable time lapse after drug hypersensitivity reaction onset. What is Known: • True drug allergy is rarely observed in children. • Absence of full workup leads to falsely labeling children as "allergic." What is New: • Short time lapse between hypersensitivity onset and consultation improves classification of pediatric allergy. • Timely allergy consultations are essential, and tests are useful to confirm or exclude pediatric allergy.
Keywords: Allergy; Drug adverse reaction; Drug provocation tests; Drug safety; Pediatrics; Skin tests.
References
-
- Erkocoglu M, Kaya A, Civelek E, Ozcan C, Cakir B, Akan A, Toyran M, Ginis T, Kocabas CN (2013) Prevalence of confirmed immediate type drug hypersensitivity reactions among school children. Pediatr Allergy Immunol 24:160–167 - DOI
-
- Gomes ER, Brockow K, Kuyucu S, Saretta F, Mori F, Blanca-Lopez N, Ott H, Atanaskovic-Markovic M, Kidon M, Caubet JC, Terreehorst I (2016) Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group. Allergy 71:149–161 - DOI
-
- Rebelo Gomes E, Fonseca J, Araujo L, Demoly P (2008) Drug allergy claims in children: from self-reporting to confirmed diagnosis. Clin Exp Allergy 38:191–198 - PubMed
-
- Ibia EO, Schwartz RH, Wiedermann BL (2000) Antibiotic rashes in children: a survey in a private practice setting. Arch Dermatol 136:849–854 - DOI
-
- Scott LA, Stone MS (2003) Viral exanthems. Dermatol Online J 9(3):4 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
